Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Lung Neuroendocrine Tumor × X-Rays × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 2 Non functioning pancreatic endocrine tumor 1 Advanced Lung Neuroendocrine Tumor 1 Adenoma, Islet Cell 1

Interventions

lutetium Lu 177 dotatate 1 X-Rays 1 Specimen Handling 1 Photons 1 Magnetic Resonance Spectroscopy 1 Fluorodeoxyglucose F18 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04665739 2026-03-17

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

National Cancer Institute (NCI)

Phase 2 Recruiting

Advanced Lung Neuroendocrine Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡